Medicine Description pegasys 180mcg/0.5 ml
Pegasys 180mcg/ml prefilled syringe is a prefilled syringe containing Peginterferon Alfa-2a, manufactured by Roche. This medication is an interferon that works by enhancing the immune response against viral infections and inhibiting viral replication. It is used primarily in the treatment of chronic hepatitis B and C, helping to reduce viral load and improve liver function.
Indications and Uses of Pegasys 180mcg/ml prefilled syringe
- Chronic hepatitis B
- Chronic hepatitis C
- Hepatitis C in combination with ribavirin
- Hepatocellular carcinoma in patients with chronic hepatitis B
How to Use Pegasys 180mcg/ml prefilled syringe
- Administer the injection subcutaneously as directed by the doctor or pharmacist.
- Rotate injection sites to avoid irritation.
- Ensure the solution is clear and free from particles before use.
- Do not shake the syringe before administration.
- Dispose of used syringes properly in a sharps container.
Contraindications of Pegasys 180mcg/ml prefilled syringe
- Hypersensitivity to Peginterferon Alfa-2a or any of its components
- Autoimmune disorders
- Severe liver impairment
- Severe psychiatric disorders
Side Effects of Pegasys 180mcg/ml prefilled syringe
- Flu-like symptoms such as fever, chills, and fatigue
- Injection site reactions including redness and swelling
- Headache
- Nausea
- Depression
- Muscle pain
Storage and Handling
Store in a refrigerator at 2°C to 8°C. Protect from light and do not freeze. Keep out of reach of children.
Warnings and Precautions
Pegasys may cause drowsiness; avoid driving if affected. Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Use with caution in children and the elderly, and seek medical attention for any unusual symptoms or side effects.